YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Big Pharma braces for retirement of FDA leader

Posted online

The retirement of Dr. Janet Woodcock as head of the Food and Drug Administration's pharmaceutical division is at least a year away, but already the industry she regulates is worrying about who will replace her, according to Reuters.

Woodcock, 65, has during the past 20 years helped to reshape the drug approval process, relaxing certain criteria. The agency approved 39 new drugs last year, the most since 1996.

Read more at Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences